Human thymus regeneration and T cell reconstitution

Seminars in Immunology

Volumn 19, Issue 5, 2007, Pages 280-288

  Legrand, Nicolas ^a   Dontje, Wendy ^a   van Lent, Anja U ^a   Spits, Hergen ^b   Blom, Bianca ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b GENENTECH INC   (United States)

Author keywords

Adoptive transfer; Bone marrow transplantation; T cell development; T cell receptor transfer; Thymic epithelial cells

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 7;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN SPECIFICITY; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL SURVIVAL; DEGENERATION; DRUG MECHANISM; DRUG MEGADOSE; EPITHELIUM CELL; GENE TRANSFER; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; LEUKEMIA; LYMPHOCYTOPENIA; LYMPHOMA; MELANOMA; NONHUMAN; REGENERATION; REVIEW; RISK ASSESSMENT; SARCOMA; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; THYMUS; THYMUS TRANSPLANTATION; UNSPECIFIED SIDE EFFECT;

ANIMALS; BONE MARROW TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MICE; RECEPTORS, ANTIGEN, T-CELL; REGENERATION; T-LYMPHOCYTES; THYMUS GLAND;

EID: 36549056948     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2007.10.001     Document Type: Review

References (109)

1. Spits H. Development of alphabeta T cells in the human thymus. Nat. Rev Immunol 2 (2002) 760-772
2. von Boehmer H., and Fehling H.J. Structure and function of the pre-T cell receptor. Annu Rev Immunol 15 (1997) 433-452
3. Blom B., Verschuren M.C., Heemskerk M.H., Bakker A.Q., van Gastel-Mol E.J., Wolvers-Tettero I.L., et al. TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation. Blood 93 (1999) 3033-3043
4. Carrasco Y.R., Trigueros C., Ramiro A.R., de Yebenes V.G., and Toribio M.L. Beta-selection is associated with the onset of CD8beta chain expression on CD4(+)CD8alphaalpha(+) pre-T cells during human intrathymic development. Blood 94 (1999) 3491-3498
5. Lind E.F., Prockop S.E., Porritt H.E., and Petrie H.T. Mapping precursor movement through the postnatal thymus reveals specific microenvironments supporting defined stages of early lymphoid development. J Exp Med 194 (2001) 127-134
6. Jenkinson E.J., Anderson G., and Owen J.J. Studies on T cell maturation on defined thymic stromal cell populations in vitro. J Exp Med 176 (1992) 845-853
7. Gray D.H., Ueno T., Chidgey A.P., Malin M., Goldberg G.L., Takahama Y., et al. Controlling the thymic microenvironment. Curr Opin Immunol 17 (2005) 137-143
8. Kingston R., Jenkinson E.J., and Owen J.J. A single stem cell can recolonize an embryonic thymus, producing phenotypically distinct T-cell populations. Nature 317 (1985) 811-813
9. Fisher A.G., Larsson L., Goff L.K., Restall D.E., Happerfield L., and Merkenschlager M. Human thymocyte development in mouse organ cultures. Int Immunol 2 (1990) 571-578
10. +CD38dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells. Blood 87 (1996) 5196-5206
11. Schmitt T.M., and Zuniga-Pflucker J.C. Induction of T cell development from hematopoietic progenitor cells by Delta-like-1 in vitro. Immunity 17 (2002) 749-756
12. Zuniga-Pflucker J.C. T-cell development made simple. Nat Rev Immunol 4 (2004) 67-72
13. Nakano T., Kodama H., and Honjo T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265 (1994) 1098-1101
14. Dontje W., Schotte R., Cupedo T., Nagasawa M., Scheeren F., Gimeno R., et al. Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B. Blood 107 (2006) 2446-2452
15. + progenitor cells mature to T cells on OP9-DL1 stromal cell line without thymus microenvironment. Blood Cells Mol Dis 33 (2004) 227-232
16. Haddad R., Guardiola P., Izac B., Thibault C., Radich J., Delezoide A.L., et al. Molecular characterization of early human T/NK and B-lymphoid progenitor cells in umbilical cord blood. Blood 104 (2004) 3918-3926
17. La Motte-Mohs R.N., Herer E., and Zuniga-Pflucker J.C. Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood 105 (2005) 1431-1439
18. Schmitt T.M., de Pooter R.F., Gronski M.A., Cho S.K., Ohashi P.S., and Zuniga-Pflucker J.C. Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nat Immunol 5 (2004) 410-417
19. de Pooter R.F., Schmitt T.M., and Zuniga-Pflucker J.C. In vitro generation of T lymphocytes from embryonic stem cells. Methods Mol Biol 330 (2006) 113-121
20. Legrand N., Weijer K., and Spits H. Experimental models to study development and function of the human immune system in vivo. J Immunol 176 (2006) 2053-2058
21. Shultz L.D., Ishikawa F., and Greiner D.L. Humanized mice in translational biomedical research. Nat Rev Immunol 7 (2007) 118-130
22. Traggiai E., Chicha L., Mazzucchelli L., Bronz L., Piffaretti J.C., Lanzavecchia A., et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304 (2004) 104-107
23. + cells injected into newborn RAG2-/- gammac-/- mice: functional inactivation of p53 in developing T cells. Blood 104 (2004) 3886-3893
24. Legrand N., Cupedo T., van Lent A.U., Ebeli M.J., Weijer K., Hanke T., et al. Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in "human immune system" Rag2(-/-)gammac(-/-) mice. Blood 108 (2006) 238-245
25. Hebart H., and Einsele H. Clinical aspects of CMV infection after stem cell transplantation. Hum Immunol 65 (2004) 432-436
26. Loren A.W., Porter D.L., Stadtmauer E.A., and Tsai D.E. Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant 31 (2003) 145-155
27. Ferrara J.L., and Reddy P. Pathophysiology of graft-versus-host disease. Semin Hematol 43 (2006) 3-10
28. Hauri-Hohl M.M., Keller M.P., Gill J., Hafen K., Pachlatko E., Boulay T., et al. Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation. Blood 109 (2007) 4080-4088
29. Apperley J.F., Jones L., Hale G., Waldmann H., Hows J., Rombos Y., et al. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant 1 (1986) 53-66
30. Giralt S., Estey E., Albitar M., van Besien K., Rondon G., Anderlini P., et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 89 (1997) 4531-4536
31. Diaconescu R., Flowers C.R., Storer B., Sorror M.L., Maris M.B., Maloney D.G., et al. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood 104 (2004) 1550-1558
32. Jimenez M., Martinez C., Ercilla G., Carreras E., Urbano-Ispizua A., Aymerich M., et al. Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation. Exp Hematol 33 (2005) 1240-1248
33. Benz C., and Bleul C.C. A multipotent precursor in the thymus maps to the branching point of the T versus B lineage decision. J Exp Med 202 (2005) 21-31
34. Schwarz B.A., and Bhandoola A. Circulating hematopoietic progenitors with T lineage potential. Nat Immunol 5 (2004) 953-960
35. Wu L., Scollay R., Egerton M., Pearse M., Spangrude G.J., and Shortman K. CD4 expressed on earliest T-lineage precursor cells in the adult murine thymus. Nature 349 (1991) 71-74
36. Allman D., Sambandam A., Kim S., Miller J.P., Pagan A., Well D., et al. Thymopoiesis independent of common lymphoid progenitors. Nat Immunol 4 (2003) 168-174
37. Heinzel K., Benz C., Martins V.C., Haidl I.D., and Bleul C.C. Bone marrow-derived hemopoietic precursors commit to the T cell lineage only after arrival in the thymic microenvironment. J Immunol 178 (2007) 858-868
38. Porritt H.E., Rumfelt L.L., Tabrizifard S., Schmitt T.M., Zuniga-Pflucker J.C., and Petrie H.T. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity 20 (2004) 735-745
39. Sambandam A., Maillard I., Zediak V.P., Xu L., Gerstein R.M., Aster J.C., et al. Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol 6 (2005) 663-670
40. Tan J.B., Visan I., Yuan J.S., and Guidos C.J. Requirement for Notch1 signals at sequential early stages of intrathymic T cell development. Nat Immunol 6 (2005) 671-679
41. Krueger A., Garbe A.I., and von Boehmer H. Phenotypic plasticity of T cell progenitors upon exposure to Notch ligands. J Exp Med 203 (2006) 1977-1984
42. Krueger A., and von Boehmer H. Identification of a T lineage-committed progenitor in adult blood. Immunity 26 (2007) 105-116
43. Hao Q.L., Zhu J., Price M.A., Payne K.J., Barsky L.W., and Crooks G.M. Identification of a novel, human multilymphoid progenitor in cord blood. Blood 97 (2001) 3683-3690
44. Dik W.A., Pike-Overzet K., Weerkamp F., de Ridder D., de Haas E.F., Baert M.R., et al. New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J Exp Med 201 (2005) 1715-1723
45. Haddad R., Guimiot F., Six E., Jourquin F., Setterblad N., Kahn E., et al. Dynamics of thymus-colonizing cells during human development. Immunity 24 (2006) 217-230
46. van den Brink M.R., Alpdogan O., and Boyd R.L. Strategies to enhance T-cell reconstitution in immunocompromised patients. Nat Rev Immunol 4 (2004) 856-867
47. Wils E.J., and Cornelissen J.J. Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement. Blood Rev 19 (2005) 89-98
48. Alpdogan O., and van den Brink M.R. IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol 26 (2005) 56-64
49. Zakrzewski J.L., Kochman A.A., Lu S.X., Terwey T.H., Kim T.D., Hubbard V.M., et al. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat Med 12 (2006) 1039-1047
50. Dallas M.H., Varnum-Finney B., Martin P.J., and Bernstein I.D. Enhanced T cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand delta1. Blood 109 (2007) 3579-3587
51. Ohishi K., Varnum-Finney B., and Bernstein I.D. Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells. J Clin Invest 110 (2002) 1165-1174
52. Besseyrias V., Fiorini E., Strobl L.J., Zimber-Strobl U., Dumortier A., Koch U., et al. Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. J Exp Med 204 (2007) 331-343
53. + cells. Exp Hematol 34 (2006) 1720-1729
54. Jameson S.C. Maintaining the norm: T-cell homeostasis. Nat Rev Immunol 2 (2002) 547-556
55. Mazzucchelli R., and Durum S.K. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 7 (2007) 144-154
56. Napolitano L.A., Grant R.M., Deeks S.G., Schmidt D., De Rosa S.C., Herzenberg L.A., et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 7 (2001) 73-79
57. Mertsching E., Burdet C., and Ceredig R. IL-7 transgenic mice: analysis of the role of IL-7 in the differentiation of thymocytes in vivo and in vitro. Int Immunol 7 (1995) 401-414
58. Morrissey P.J., Conlon P., Charrier K., Braddy S., Alpert A., Williams D., et al. Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy. J Immunol 147 (1991) 561-568
59. Bolotin E., Smogorzewska M., Smith S., Widmer M., and Weinberg K. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 88 (1996) 1887-1894
60. Alpdogan O., Schmaltz C., Muriglan S.J., Kappel B.J., Perales M.A., Rotolo J.A., et al. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 98 (2001) 2256-2265
61. Alpdogan O., Muriglan S.J., Eng J.M., Willis L.M., Greenberg A.S., Kappel B.J., et al. IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J Clin Invest 112 (2003) 1095-1107
62. Broers A.E., Posthumus-van Sluijs S.J., Spits H., van der Holt B., Lowenberg B., Braakman E., et al. Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants. Blood 102 (2003) 1534-1540
63. + T-regulatory cells. J Immunother 29 (2006) 313-319
64. Khoruts A., and Fraser J.M. A causal link between lymphopenia and autoimmunity. Immunol Lett 98 (2005) 23-31
65. Centlivre M., Sommer P., Michel M., Ho Tsong Fang R., Gofflo S., Valladeau J., et al. HIV-1 clade promoters strongly influence spatial and temporal dynamics of viral replication in vivo. J Clin Invest 115 (2005) 348-358
66. Anderson G., Jenkinson W.E., Jones T., Parnell S.M., Kinsella F.A., White A.J., et al. Establishment and functioning of intrathymic microenvironments. Immunol Rev 209 (2006) 10-27
67. Bastian J., Law S., Vogler L., Lawton A., Herrod H., Anderson S., et al. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr 115 (1989) 391-396
68. Markert M.L., Hummell D.S., Rosenblatt H.M., Schiff S.E., Harville T.O., Williams L.W., et al. Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr 132 (1998) 15-21
69. Hong R., Schulte-Wissermann H., Jarrett-Toth E., Horowitz S.D., and Manning D.D. Transplantation of cultured thymic fragments. II. Results in nude mice. J Exp Med 149 (1979) 398-415
70. Waer M., Palathumpat V., Sobis H., and Vandeputte M. Induction of transplantation tolerance in mice across major histocompatibility barrier by using allogeneic thymus transplantation and total lymphoid irradiation. J Immunol 145 (1990) 499-504
71. Kamano C., Vagefi P.A., Kumagai N., Yamamoto S., Barth R.N., LaMattina J.C., et al. Vascularized thymic lobe transplantation in miniature swine: thymopoiesis and tolerance induction across fully MHC-mismatched barriers. Proc Natl Acad Sci USA 101 (2004) 3827-3832
72. McCune J.M., Namikawa R., Kaneshima H., Shultz L.D., Lieberman M., and Weissman I.L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241 (1988) 1632-1639
73. + cell transplantation. Blood 108 (2006) 487-492
74. Melkus M.W., Estes J.D., Padgett-Thomas A., Gatlin J., Denton P.W., Othieno F.A., et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12 (2006) 1316-1322
75. Barry T.S., Jones D.M., Richter C.B., and Haynes B.F. Successful engraftment of human postnatal thymus in severe combined immune deficient (SCID) mice: differential engraftment of thymic components with irradiation versus anti-asialo GM-1 immunosuppressive regimens. J Exp Med 173 (1991) 167-180
76. Jenkinson E.J., Franchi L.L., Kingston R., and Owen J.J. Effect of deoxyguanosine on lymphopoiesis in the developing thymus rudiment in vitro: application in the production of chimeric thymus rudiments. Eur J Immunol 12 (1982) 583-587
77. Markert M.L., Kostyu D.D., Ward F.E., McLaughlin T.M., Watson T.J., Buckley R.H., et al. Successful formation of a chimeric human thymus allograft following transplantation of cultured postnatal human thymus. J Immunol 158 (1997) 998-1005
78. Markert M.L., Sarzotti M., Ozaki D.A., Sempowski G.D., Rhein M.E., Hale L.P., et al. Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood 102 (2003) 1121-1130
79. Nobori S., Shimizu A., Okumi M., Samelson-Jones E., Griesemer A., Hirakata A., et al. Thymic rejuvenation and the induction of tolerance by adult thymic grafts. Proc Natl Acad Sci USA 103 (2006) 19081-19086
80. Alpdogan O., Hubbard V.M., Smith O.M., Patel N., Lu S., Goldberg G.L., et al. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood 107 (2006) 2453-2460
81. Min D., Panoskaltsis-Mortari A., Kuro O.M., Hollander G.A., Blazar B.R., and Weinberg K.I. Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood 109 (2007) 2529-2537
82. Rossi S.W., Jeker L.T., Ueno T., Kuse S., Keller M.P., Zuklys S., et al. Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells. Blood 109 (2007) 3803-3811
83. Gill J., Malin M., Hollander G.A., and Boyd R. Generation of a complete thymic microenvironment by MTS24(+) thymic epithelial cells. Nat Immunol 3 (2002) 635-642
84. Bennett A.R., Farley A., Blair N.F., Gordon J., Sharp L., and Blackburn C.C. Identification and characterization of thymic epithelial progenitor cells. Immunity 16 (2002) 803-814
85. Poznansky M.C., Evans R.H., Foxall R.B., Olszak I.T., Piascik A.H., Hartman K.E., et al. Efficient generation of human T cells from a tissue-engineered thymic organoid. Nat Biotechnol 18 (2000) 729-734
86. Clark R.A., Yamanaka K., Bai M., Dowgiert R., and Kupper T.S. Human skin cells support thymus-independent T cell development. J Clin Invest 115 (2005) 3239-3249
87. Papadopoulos E.B., Ladanyi M., Emanuel D., Mackinnon S., Boulad F., Carabasi M.H., et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 330 (1994) 1185-1191
88. Walter E.A., Greenberg P.D., Gilbert M.J., Finch R.J., Watanabe K.S., Thomas E.D., et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333 (1995) 1038-1044
89. Einsele H., Roosnek E., Rufer N., Sinzger C., Riegler S., Loffler J., et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 99 (2002) 3916-3922
90. Rooney C.M., Smith C.A., Ng C.Y., Loftin S., Li C., Krance R.A., et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345 (1995) 9-13
91. Rooney C.M., Smith C.A., Ng C.Y., Loftin S.K., Sixbey J.W., Gan Y., et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92 (1998) 1549-1555
92. Orentas R.J., Lemas M.V., Mullin M.J., Colombani P.M., Schwarz K., and Ambinder R. Feasibility of cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using haploidentical donors. J Hematother 7 (1998) 257-261
93. Haque T., Wilkie G.M., Taylor C., Amlot P.L., Murad P., Iley A., et al. Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet 360 (2002) 436-442
94. Savoldo B., Goss J.A., Hammer M.M., Zhang L., Lopez T., Gee A.P., et al. Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). Blood 108 (2006) 2942-2949
95. Rosenberg S.A., Yannelli J.R., Yang J.C., Topalian S.L., Schwartzentruber D.J., Weber J.S., et al. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J Natl Cancer Inst 86 (1994) 1159-1166
96. Rosenberg S.A., and Dudley M.E. Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes. Proc Natl Acad Sci USA 101 Suppl. 2 (2004) 14639-14645
97. Dudley M.E., Wunderlich J.R., Yang J.C., Sherry R.M., Topalian S.L., Restifo N.P., et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23 (2005) 2346-2357
98. Gattinoni L., Powell Jr. D.J., Rosenberg S.A., and Restifo N.P. Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 6 (2006) 383-393
99. Kessels H.W., Wolkers M.C., van den Boom M.D., van der Valk M.A., and Schumacher T.N. Immunotherapy through TCR gene transfer. Nat Immunol 2 (2001) 957-961
100. Zhao Y., Zheng Z., Robbins P.F., Khong H.T., Rosenberg S.A., and Morgan R.A. Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines. J Immunol 174 (2005) 4415-4423
101. Xue S.A., Gao L., Hart D., Gillmore R., Qasim W., Thrasher A., et al. Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells. Blood 106 (2005) 3062-3067
102. Morgan R.A., Dudley M.E., Wunderlich J.R., Hughes M.S., Yang J.C., Sherry R.M., et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314 (2006) 126-129
103. Schumacher T.N. T-cell-receptor gene therapy. Nat Rev Immunol 2 (2002) 512-519
104. van der Veken L.T., Hagedoorn R.S., van Loenen M.M., Willemze R., Falkenburg J.H., and Heemskerk M.H. Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity. Cancer Res 66 (2006) 3331-3337
105. Heemskerk M.H., Hagedoorn R.S., van der Hoorn M.A., van der Veken L.T., Hoogeboom M., Kester M.G., et al. Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex. Blood 109 (2007) 235-243
106. + T cells. J Clin Invest 115 (2005) 1616-1626
107. Yang L., and Baltimore D. Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells. Proc Natl Acad Sci USA 1021 (2005) 4518-4523
108. van Lent A.U., Nagasawa M., van Loenen M.M., Schotte R., Schumacher T.N., Heemskerk M.H., et al. Functional human antigen-specific T cells produced in vitro using retroviral T cell receptor transfer into hematopoietic progenitors. J Immunol 179 (2007) 4959-4968
109. Zhao Y., Parkhurst M.R., Zheng Z., Cohen C.J., Riley J.P., Gattinoni L., et al. Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling. Cancer Res 67 (2007) 2425-2429